Official 2024 U.S. DOL Form 5500 summary for Aquestive Therapeutics (Aquestive Therapeutics 401(k) Plan · EIN 82-3827296 · PN 001): $23.38M net assets, 150 active participants, and Sponsor-paid or unbenchmarked.
| Plan Sponsor | Aquestive Therapeutics |
|---|---|
| Filing Identifier | Aquestive Therapeutics 401(k) Plan · EIN 82-3827296 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (IN) |
| Asset-Size Peer Cohort | $5M-$25M |
| Plan Net Assets (2024) | $23.38M |
| Active Participants | 150 |
| Direct Admin Fee Rate | Sponsor-paid or unbenchmarked |
| Cohort Peer Median | N/A |
| Primary Recordkeeper / Provider | Wells Fargo Clearing Services LLC |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($3,065, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI